Comprehensive Solutions for Infectious Disease Research
Approximately 60-70% of infectious diseases are viral, including COVID-19, influenza, MPXV, HIV, and Ebola. These viruses continue to affect human health and socio-economic development. Therefore, it is crucial to continuously monitor emerging viral strains and rapidly develop vaccines and treatments for emerging infectious diseases.
Sino Biological, a global supplier of viral reagents with over 15 years of R&D experience, is committed to supporting virology and infectious disease research. Our viral reagent bank focuses on new outbreaks, the latest viral strains and vaccine strains, and critical molecules, empowering researchers to address emerging health threats quickly. Sino Biological now provides comprehensive solutions for infectious disease research, supporting basic virus research and the development of vaccines, drugs, ELISA kits, and diagnostic reagents.
Learn more about solutions for infectious disease research!
A Wide Range of Applications:
1. Vaccine Development
Sino Biological offers a comprehensive suite of solutions for the development of a broad spectrum of vaccines, such as inactivated, recombinant protein, DNA, mRNA, and viral vector vaccines.
2. Diagnostic Development
High-quality antigens, antibodies, and other core reagents for immunodiagnosis fully support accurate detection and disease monitoring.
3. Drug Development
Premium antiviral drug targets cover key targets for COVID-19 small-molecule drugs and targets for Mpox, influenza, RSV, and HIV, supporting the development of antiviral drugs.
4. Infectious Disease Research
High-quality reagents for infectious disease research support scientific research, vaccine and diagnostics development, as well as drug discovery efforts.
